Expanded Access includes:
- Emergency Use
- Compassionate Use
- Treatment Use
- Continued Access
These options are defined on the FDA website and in the Guidance on IDE Policies and Procedures. The guidance document provides a concise table summarizing the expanded access mechanisms and the requirements.
If you have specific questions regarding the expanded access options, please contact the appropriate IDE staff using the phone number information provided on the website or guidance document.
